Erlotinib Terminated Phase 2 Trials for Polycythemia Vera (PV) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01038856Trial of Erlotinib in Patients With JAK-2 V617F Positive Polycythemia Vera